Perspective Therapeutics, Inc.
CATX
$2.12
-$0.08-3.43%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -103.15% | -100.68% | -25.76% | -45.30% | -107.49% |
| Total Depreciation and Amortization | 265.47% | 483.06% | 222.85% | 241.18% | 23.03% |
| Total Amortization of Deferred Charges | 0.00% | 0.00% | 0.00% | 0.00% | -- |
| Total Other Non-Cash Items | 91.81% | 102.45% | 70.98% | 314.26% | 330.75% |
| Change in Net Operating Assets | -123.61% | -105.12% | -101.70% | 1,083.01% | 3,208.50% |
| Cash from Operations | -12,031.18% | -357.06% | -302.67% | 50.44% | 97.84% |
| Capital Expenditure | 42.67% | -432.69% | -392.64% | -4,881.25% | -3,623.56% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -171.79% | -213.84% | -227.53% | -814.73% | -231.29% |
| Cash from Investing | -56.57% | -233.23% | -267.74% | -998.25% | -361.19% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -27.50% | -20.00% | 36.92% | 41.18% | 28.57% |
| Issuance of Common Stock | -93.81% | -93.54% | -93.64% | 18,089.98% | 30,107.22% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 443,261.54% | 100.00% |
| Cash from Financing | -96.32% | -96.16% | -20.43% | 36,764.33% | 66,734.18% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -195.87% | -199.84% | -192.64% | 543.73% | 20,803.58% |